Tredaptive

País: Nova Zelanda

Idioma: anglès

Font: Medsafe (Medicines Safety Authority)

ingredients actius:

Laropiprant 20mg;  ; Nicotinic acid 1000mg

Disponible des:

Merck Sharp & Dohme (New Zealand) Limited

Designació comuna internacional (DCI):

Laropiprant 20 mg

formulario farmacéutico:

Tablet

Composición:

Active: Laropiprant 20mg   Nicotinic acid 1000mg Excipient: Colloidal silicon dioxide Croscarmellose sodium Hyprolose Hypromellose Lactose monohydrate Magnesium stearate Microcrystalline cellulose Sodium stearyl fumarate

Unidades en paquete:

Blister pack, Al/Al - 7 tablets, 7 tablets

clase:

Prescription

tipo de receta:

Prescription

Fabricat per:

F.I.S. Fabbrica Italiana Sintetici SpA

Resumen del producto:

Package - Contents - Shelf Life: Blister pack, Al/Al - 7 tablets - 7 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al - 14 tablets - 14 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al - 28 tablets - 28 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al - 56 tablets - 56 tablets - 24 months from date of manufacture stored at or below 30°C

Data d'autorització:

2007-08-29